Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study

by Javier Riancho, Javier Riancho, Javier Riancho, Javier Riancho, Sonia Setien, Jose Ramón Sánchez de la Torre, Marta Torres-Barquin, Mercedes Misiego, José Luis Pérez, Tamara Castillo-Triviño, Tamara Castillo-Triviño, Cristina Menéndez-García, Manuel Delgado-Alvarado, Manuel Delgado-Alvarado
Published 2021-03-01